29.04.2014 15:19
SomPharmaceuticals S.A., a biopharmaceutical company developing novel therapies for rare diseases, announced today the closure of its Series A financing with an additional private placement of 750,000 CHF. Taken together with other private and public funding sources, SomPharmaceuticals’ total gross proceeds reached its 1,100,000 CHF funding target.